Project Grant R35GM151971
Award Date
7/15/24
Completion Date
6/30/29
Dollars Obligated
$789K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant totaling $853,844 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Nebraska Medical Center (UNMC) to characterize the function of cyclic di-AMP on Chlamydia growth and differentiation. This two-year research project aims to investigate why the obligate intracellular bacteria Chlamydia produces the second messenger compound cyclic di-AMP, which is typically...
This Project Grant award of $130,950.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand the developmental cycle of Chlamydia bacteria at the single-cell level. The primary goals are to 1) develop a CRISPR interference screen to assess the role of essential genes in regulating the distinct Chlamydia cell types, and 2) investigate the function of cell-type specific...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $207,225 R21 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Nebraska Medical Center (UNMC). The grant supports research to investigate how the chlamydia pathogen manipulates the host cell's PICALM protein to promote a "silent" infection and obtain nutrients. Specifically, the research aims to understand how chlamydia interacts with PICALM in the Golgi...
This federal Project Grant award for $583,698.00, funded by the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859), supports research to decode the rules governing coordination of the bacterial cell cycle. The project aims to: (i) define the mechanisms by which the replication initiator DnaA and the partitioning system ParABS coordinate the initiation of chromosome replication with centromere segregation, and (ii) uncover...
This $214,363 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program supports research to investigate the functional relevance of the tryptophan operon polymorphism in Chlamydia trachomatis. The research aims to better understand the regulatory mechanisms controlling tryptophan biosynthesis in C. trachomatis, including the role of the YtgR repressor in transcriptional adaptation...
This Project Grant award of $202,500.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program will fund research to develop a better understanding of the Chlamydial developmental cycle at the single cell level. The primary aims of the project are to: 1) Develop a CRISPR-interference (CRISPRi) knockdown screen to assess the role of essential genes in regulating Chlamydial cell type development, and 2)...
This federal Project Grant award of $462,500.00 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) will support research to decipher the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics. The research aims to comprehensively characterize bacterial heterogeneity during antibiotic treatment and identify the underlying genetic regulators that could...
This $1,003,736 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to expand the understanding of post-transcriptional regulation of gene expression in bacteria. The research will focus on two key areas: 1) Epitranscriptomic regulation of gene expression across the prokaryotic domain, examining RNA modifications and their regulatory roles, and 2) Post-transcriptional gene regulation via novel...
The National Institute of General Medical Sciences (NIGMS) awarded a $463,157 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of California, Berkeley. The grant supports research to measure and model how antimicrobial resistance (AMR) evolution depends on the self-organization of bacterial populations, ranging from microscale biofilms to gut-lumen distributed populations. Key objectives include advancing synthetic mutagenesis techniques...
This $441,250 Project Grant was awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Washington. The funding will support a 5-year research project to investigate regulators of bacterial chromosome organization. Specifically, the research aims to elucidate the mechanism of the bacterial protein GAPR as a model for understanding how bacteria and bacteriophages (viruses) control positive...